TABLE 2.
FarR variants that occur independently of clonal complex diversitya
| Variant | No. of genomes | MLST/CC | Source |
|---|---|---|---|
| H121Y | 8 | CC1 (ST2922), CC97, CC8, ST30, CC22; (EMRSA-15) | Human (CC1, ST30, ST8, CC22) and bovine (CC97) |
| C116Y | 19 | CC1 (ST3117), CC97 (ST97, ST71, ST3221, ST3109, ST3173), CC8 | Bovine mastitis infection and milk; UK, Switzerland, Ireland, Turkey, Chile |
| 16 | ST5/CC5 | HA-MRSA; US, Canada | |
| E93EE | 61 | CC5 (ST5, ST764) | HA-MRSA; Japan, China, Thailand, Europe, US |
| E160G | 82 | ST5/CC5 | USA100 HA-MRSA; Israel, US, UK, Australia, Europe |
| P165L | 34 | ST5/CC5 | HA-MRSA; US, Canada, Egypt, UK, Europe |
| 2 | ST15 | Scotland; MSSA | |
| G166D | 5 | ST8 and CC97 | Human ST8 (US and Norway) and bovine CC97 (UK) |
| 5 | ST5 | HA-MRSA; US and Netherlands |
a
MLST, multilocus sequence type; CC, clonal complex; ST, sequence type; HA-MRSA, hospital-acquired MRSA; MSSA, methicillin-susceptible S. aureus.